Home/Filings/4/0001415889-24-001646
4//SEC Filing

Lund-Hansen Torben 4

Accession 0001415889-24-001646

CIK 0001722964other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 5:54 PM ET

Size

15.2 KB

Accession

0001415889-24-001646

Insider Transaction Report

Form 4
Period: 2024-01-18
Lund-Hansen Torben
Sr VP & Head of Technical Oper
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-01-18+35,70035,700 total
    Exercise: $9.83Exp: 2034-01-18Common Stock (35,700 underlying)
  • Award

    Common Stock

    2024-01-18+17,80035,600 total
Holdings
  • Common Stock

    (indirect: By Toluha ApS)
    45,662
Footnotes (4)
  • [F1]Represents 17,800 restricted stock units ("RSUs") granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each RSU represents a contingent right to receive one share of Common Stock on the vesting dates of the RSU. The RSUs vest by 1/3 on each of January 18, 2025, January 18, 2026 and January 18, 2027 subject to the continuing employment of the Reporting Person on each vesting date.
  • [F2]Reporting Person is sole member of Toluha ApS.
  • [F3]Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
  • [F4]The stock options shall vest and become exercisable as to 25% of the shares subject to the option on January 18, 2025, and thereafter vest and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Issuer

Y-mAbs Therapeutics, Inc.

CIK 0001722964

Entity typeother

Related Parties

1
  • filerCIK 0001753134

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 5:54 PM ET
Size
15.2 KB